coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Central And North Guildford PCN, Guildford · Health Inequalities Profile

    PCN U86623 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    43,566

    Registered population

    67.6% aged 18–64

    15.4%

    Aged 65+

    ICB 18.8% · England 17.9%

    16.8%

    Ethnic minority (non-White)

    9.0% Asian · England 9.6%

    1.6%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~689

    Core20 residents (est.)

    Resident basis; registered basis ~743 · see page 3

    5,431

    Hypertension register

    +3.30% in 3 yrs · England +5.60%

    406

    SMI register

    37.9% of Guildford's

    571

    COPD register

    Reviews -8.33% in 3 yrs

    Forecast to 2030

    6,476

    Hypertension patients, 2030

    +1,045 on today

    62.4%

    QRISK ≥20% on statins, 2030

    +2.90pp over 3 yrs

    4.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    951
    Asthma annual reviews fall behind national growth.

    Over 2023 to 2025, asthma reviews fell 4.7% (England +4.4%) to 63.1%, leaving 951 of 2,577 patients unreviewed, which may reflect recall gaps.

    56.1%
    High-risk lipid therapy coverage trails England.

    Lipid-lowering therapy for QRISK ≥ 20% is 56.1%, below Guildford (57.3%), the ICB (59.4%) and England by 7.4 pp (63.6%), warranting recall audit.

    +11.6%
    Hypertension treatment to target improved over three years.

    Over 2023 to 2025, hypertension control rose +11.6% (+7.2 pp versus England +2.5 pp), reaching 69.2% against 70.3% across England.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A working-age population predominates alongside 8.8% projected list growth to 2030

    Central and North Guildford PCN registers 43,566 patients across Woodbridge Hill Surgery (17,144), Fairlands Medical Practice (13,966), and Dapdune House Surgery (12,456). Working-age adults aged 18–64 account for 67.6% (Guildford 63.8%, ICB 60.8%, England 62.7%). Patients aged 65+ represent 15.4% (6,725; Guildford 17.5%, England 17.9%). An unverified model projects 8.8% list growth to 2030 (England 2.3%). In Census resident data, not registered patients, White ethnicity is 83.2% (England 81.1%) and Asian is 9.0% (Guildford 6.7%, England 9.6%), reaching 11.2% at Woodbridge Hill Surgery and 10.2% at Dapdune House Surgery.

    Age profile

    0–1716.9%
    18–6467.6%
    65+15.4%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White83.2%
    Asian9.0%
    Mixed3.6%
    Other2.4%
    Black1.8%

    Older people · falls rows are Guildford local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Guildford LA)2,1632,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.6%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Guildford LA)1,0549819552024/25
    Falls deaths, all ages, per 100,000 (Guildford LA)9.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 1.6% of patients, concentrating mostly at Woodbridge Hill Surgery

    Central and North Guildford PCN records an average IMD decile of 7.6 (Guildford 7.9, NHS Surrey Heartlands Integrated Care Board 7.9, England 5.5). Core20 prevalence is 1.6% (Guildford 1.0%, ICB 0.8%, England 21.0%). Resident Core20 estimates total 689 persons across deciles 1 and 2, which differ from 743 across practice registers. Both Core20 concentration and volume peak at Woodbridge Hill Surgery (2.3%, 389 estimated patients), ahead of Dapdune House Surgery (1.6%, 206) and Fairlands Medical Practice (1.1%, 148).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Woodbridge Hill2.3% · 389 patients
    Dapdune House1.6% · 206 patients
    Fairlands Medical1.1% · 148 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    406

    SMI register

    0.94% recorded prevalence

    185

    Learning disability register

    0.43% recorded prevalence

    18

    Care homes, 581 beds

    In the PCN catchment

    8.0%

    Provide unpaid care

    Guildford, Census 2021

    Recorded learning disability prevalence is 0.4% (185 patients; Guildford 0.4%, ICB 0.5%, England 0.6%), and severe mental illness is 0.9% (406 patients; Guildford 0.8%, ICB 0.8%, England 1.0%). Catchment care homes total 18 with 581 beds, without confirmed registered residency.

    Severe mental illness: physical health checks

    SMI physical checks trail England for blood pressure (81.5% vs 83.4%) and BMI (79.4% vs 82.1%), with Fairlands Medical Practice recording 76.9% for blood pressure. These shortfalls could reflect recall capacity gaps to verify locally.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,431

    Hypertension register

    +3.30%

    Register growth, 3 yrs

    Guildford +5.63% · England +5.60%

    +8.59pp

    BP control, under 80

    ≤140/90 · +5.18pp aged 80+

    +1,045

    More patients by 2030

    Forecast 6,476 (13.35%)

    Hypertension case-finding and control

    Hypertension prevalence is 12.5% (5,431 patients), matching Guildford (12.5%) but below NHS Surrey Heartlands ICB (14.3%) and England (15.2%). Although treatment to target rose +11.6% (+7.2 pp versus England +2.5 pp) over 2023 to 2025, current control is 69.2% (England 70.3%). Blood pressure control among patients aged 80 and over trails at 77.9% against England (81.2%), reaching 74.4% at Dapdune House Surgery and 80.6% at Woodbridge Hill Surgery. Unadjusted register scenarios (+13 to +1,204 patients) are likely overstated given the PCN's younger population (15.4% aged 65+). Older hypertensive patients remain below national control benchmarks, so prioritising structured clinical reviews at practices with lower control rates could narrow the management gap.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy coverage is 56.1%, below Guildford (57.3%), NHS Surrey Heartlands ICB (59.4%), and England (63.6%). CKD lipid coverage also trails England (63.6% versus 70.3%). Fewer at-risk patients receive lipid-lowering therapy than England implies, so prioritising recall audits for high-risk cohorts is an immediate operational step.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202642,989£2.20£2.24£1.86£94,576
    Cardiovascular (all), 202563,950£5.16£4.74£3.33£329,982

    In 2026, the PCN prescribed 42,989 items of lipid-regulating drugs at £2.20 per item (Guildford £2.15, NHS Surrey Heartlands ICB £2.24, England £1.86), spending £14,616 more than at England's unit cost. Higher unit costs than England suggest an opportunity to review local formulary choices and item mix across practices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −4.73%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.70%

    Asthma prevalence, PCN 3-yr % change

    Annual respiratory reviews have declined: COPD reviews fell 8.3% to 76.7% over 2023 to 2025 (England +2.8% to 76.4%), and asthma reviews fell 4.7% to 63.1% (England +4.4% to 65.7%). Across 2,577 asthma patients, about 950 lack a recorded review, reaching 55.9% at Woodbridge Hill Surgery. Meanwhile, asthma management prescribing reaches 1,225 items per 1,000 aged 5-19, above Guildford (838). Falling reviews alongside higher local prescribing may reflect recall pressures to verify locally.

    Cancer register and children's immunisation

    Cancer register prevalence is 3.5% (1,537 patients), below England (3.8%). In Q1 2025/26, 4-in-1 booster coverage at age 5 reached 89.1% (denominator 92), below the 95.0% target by 5.9 pp. Age-5 MMR drops 5.5 pp between dose 1 (95.7%) and dose 2 (90.2%), widening to an 11.4 pp drop at Woodbridge Hill Surgery (100.0% to 88.6%), which could reflect recall gaps to verify locally.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.6%

    England 91.0%

    6-in-1 complete primary course at 24 months92.6%

    England 92.2%

    MMR dose 1 at 24 months90.5%

    England 88.3%

    MMR dose 2 at age 590.2%

    England 82.8%

    4-in-1 pre-school booster at age 589.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    At ICB level in 2022 (not published at PCN level), NHS Surrey Heartlands ICB diagnosed 61.4% of staged cancers at stage 1 or 2 (England 55.3%), 13.6 pp below the 75.0% national ambition, requiring about 650 extra early-stage cases annually across 4,810 staged cases (67.7% known stage). PCN cancer prevalence is 3.5% across 1,537 patients (England 3.8%). Cervical screening coverage at ages 25-49 is 61.0%, below England (66.8%) and the ICB (69.3%) after a -2.9% three-year change over 2023 to 2025 (England -1.0%), reaching 56.5% at Woodbridge Hill Surgery and 57.0% at Dapdune House Surgery. Prioritising screening uptake at lower-coverage practices could support earlier presentation across local pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At acute trust level (not PCN performance), July 2026 provisional cancer 62-day waits at Royal Surrey NHS Foundation Trust reached 84.5% (standard 85.0%), above NHS Surrey and Sussex Integrated Care Board (71.5%), England (71.2%), and Ashford and St Peter's Hospitals NHS Foundation Trust (76.4%), with Frimley Health NHS Foundation Trust at 81.8%. Faster diagnosis reached 82.6% (standard 75.0%; ICB 79.3%, England 79.3%) and 31-day treatment 96.4% (standard 96.0%). Diagnostic 6-week waits were 8.8% (England 23.1%), with colonoscopy at 0.0% but audiology assessments at 49.7% (Ashford and St Peter's 0.6%, England 41.5%).

    Pathways within standard (%)Royal SurreyFrimley HealthAshford and St Peter'sSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)82.6287.9585.5379.2979.32
    31-day treatment (96%)96.4392.8994.2190.4592.50
    62-day referral to treatment (85%)84.4881.8476.3871.5171.16
    Diagnostic waits over 6 weeks (%)Royal SurreyFrimley HealthAshford and St Peter'sEngland
    MRI0.0012.850.0921.40
    CT0.150.639.279.92
    Echocardiography1.553.350.9728.48
    Colonoscopy0.0022.8449.6130.83
    Gastroscopy0.007.4356.7429.02
    All 15 DM01 tests8.827.4923.1223.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026 (provisional), Surrey residents recorded 109,530 community care contacts and 66,060 care activities, with 69.6% of contacts among adults aged 65+. Across NHS Surrey and Sussex Integrated Care Board, recorded activity totalled 309,615 care contacts and 316,320 care activities. These experimental figures reflect submitting providers across the wider system rather than exclusive PCN caseloads.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination achievement varies by 44.1 pp across practices despite uniform telephone access

    In 2025/26, clinical-domain QOF achievement reached 100.0% at Dapdune House Surgery against England's 97.1%, 100.0% at Woodbridge Hill Surgery, and 97.2% at Fairlands Medical Practice. In contrast, vaccination and immunisation achievement spanned a 44.1 pp range, from 42.7% at Fairlands Medical Practice to 86.8% at Dapdune House Surgery (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Fairlands Medical1141.167.4%76.6%87.0%
    Woodbridge Hill1202.366.3%54.6%77.2%
    Dapdune House821.666.1%77.1%75.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNGuildfordAssetPCNGuildford
    Care homes (catchment)18 (581 beds)n/aSchools (catchment)74n/a
    Children's centres46Places of worship3778
    Librariesn/a3Homelessness support (VCS)01
    Day centres (VCS)n/a2Carers support groups (VCS)n/a1
    Primary schools (LA maintained)514Primary academies1119
    Special schools1no data

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    Asthma reviews are 63.1% (Guildford 67.8%, ICB 65.6%, England 65.7%; 55.9% at Woodbridge Hill Surgery) after falling 4.7% over 2023 to 2025 (England +4.4%), leaving 951 of 2,577 patients unreviewed. For discussion: run single-template asthma recall alongside inhaler prescribing checks, offering flexible review slots at lower-coverage practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined SMI physical health checks

    Across 406 SMI register patients, annual blood pressure checks are 81.5% (Guildford 84.9%, ICB 83.5%, England 83.4%; Fairlands Medical Practice 76.9%) and BMI checks are 79.4% (England 82.1%). For discussion: introduce combined physical check appointments, template audits for partial checks, and named outreach leads for non-attenders. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    High-risk CVD lipid therapy recall

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 56.1%, below Guildford (57.3%), ICB (59.4%), and England (63.6%) after +5.4% change over 2023 to 2025; CKD lipid therapy is 63.6% (England 70.3%). Moderate effort to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Systematic SMI physical checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Appointment booking and queue review (p9)GPPS last request led to a booked appointment10YHP, hospital to communityPractice
    Option 1 · Structured asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Combined SMI physical health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · High-risk CVD lipid therapy recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy—PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15